July 2023
1. DOMINGO C, Mirapeix RM, Gonzalez-Barcala FJ, Forne C, et al
   Omalizumab in Severe Asthma: Effect on Oral Corticosteroid Exposure and Remodeling. A Randomized Open-Label Parallel Study.
   Drugs. 2023 Jul 12. doi: 10.1007/s40265-023-01905.
   

   >> Share

   
   June 2023
2. CAZZOLA M, Rogliani P, Matera MG
   Might It Be Appropriate to Anticipate the Use of Long-Acting Muscarinic Antagonists in Asthma?
   Drugs. 2023 Jun 12. doi: 10.1007/s40265-023-01897.
   

   >> Share

   
   June 2022
3. LEE A, Lamb YN, Shirley M
   Delafloxacin: A Review in Community-Acquired Pneumonia.
   Drugs. 2022;82:913-923.
   

   >> Share

   
   March 2022
4. HOY SM
   Tezepelumab: First Approval.
   Drugs. 2022;82:461-468.
   

   >> Share

   
   October 2021
5. DOMINGO RIBAS C, Carrillo Diaz T, Blanco Aparicio M, Martinez Moragon E, et al
   Correction to: REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study.
   Drugs. 2021 Oct 21. pii: 10.1007/s40265-021-01622.
   

   >> Share

   
   September 2021
6. DOMINGO RIBAS C, Carrillo Diaz T, Blanco Aparicio M, Martinez Moragon E, et al
   REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study.
   Drugs. 2021 Sep 29. pii: 10.1007/s40265-021-01597.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share